In England, to gain a positive recommendation for use within the NHS from NICE, pharmaceutical produ...
Read moreA targeted drug has been accepted for routine use on the NHS in England for some adults with untreat...
Read moreBy joining together, countries can combine their resources to potentially increase the efficiency of...
Read morePharmaceutical pricing and market access is the crucial challenge for successful product launch toda...
Read moreWhat is the future of precision medicine in the EU? The field of precision medicine is a complex are...
Read moreNICE will continue to offer joint advice with the Medicines and Healthcare products Regulatory Agenc...
Read moreThe law provides a legal framework for the automatic substitution of biosimilars at the level of the...
Read moreThe deadlock between Vertex and NHS over the cystic fibrosis drug Orkambi was played out in a parlia...
Read moreThe ABPI is working closely with the Department of Health and Social Care, NHS England and NICE to e...
Read moreNICE was the first EU HTA body to provide their assessment of Kymriah for ALL, publishing their opin...
Read more